CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector

Gene therapy using recombinant adeno-associated viral (AAV) vectors is emerging as a promising approach to treat central nervous system disorders such as Spinal muscular atrophy, Batten, Parkinson and Alzheimer disease amongst others. A critical remaining challenge for central nervous system-targete...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Nucleic Acids
Main Authors: Murlidharan, Giridhar, Sakamoto, Kensuke, Rao, Lavanya, Corriher, Travis, Wang, Dan, Gao, Guangping, Sullivan, Patrick, Asokan, Aravind
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330941/
https://ncbi.nlm.nih.gov/pubmed/27434683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2016.49
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados